Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 194


Detection of silent myocardial ischemia in asymptomatic patients with diabetes: results of a randomized trial and meta-analysis assessing the effectiveness of systematic screening.

Lièvre MM, Moulin P, Thivolet C, Rodier M, Rigalleau V, Penfornis A, Pradignac A, Ovize M; DYNAMIT investigators.

Trials. 2011 Jan 26;12:23. doi: 10.1186/1745-6215-12-23.


Predictive value of silent myocardial ischemia for cardiac events in diabetic patients: influence of age in a French multicenter study.

Valensi P, Pariès J, Brulport-Cerisier V, Torremocha F, Sachs RN, Vanzetto G, Cosson E, Lormeau B, Attali JR, Maréchaud R, Estour B, Halimi S.

Diabetes Care. 2005 Nov;28(11):2722-7.


Prevalence and predictors of ischemia and outcomes in outpatients with diabetes mellitus referred for single-photon emission computed tomography myocardial perfusion imaging.

Bourque JM, Patel CA, Ali MM, Perez M, Watson DD, Beller GA.

Circ Cardiovasc Imaging. 2013 May 1;6(3):466-77. doi: 10.1161/CIRCIMAGING.112.000259. Epub 2013 Apr 1.


[Incidence and prognostic value of ischemic heart disease in high risk cardiovascular asymptomatic diabetic patients detected by gated myocardial perfusion SPECT study].

Ruano Pérez R, Gómez-Caminero López F, Diego Domínguez M, Martín De Arriba A, Martín Luengo C, García-Talavera Fernández JR.

Rev Esp Med Nucl Imagen Mol. 2012 Mar-Apr;31(2):83-8. doi: 10.1016/j.remn.2011.04.012. Epub 2011 Sep 22. Spanish.


Myocardial perfusion imaging and cardiac events in a cohort of asymptomatic patients with diabetes living in southern France.

Sultan A, Piot C, Mariano-Goulart D, Daures JP, Comte F, Renard E, Avignon A.

Diabet Med. 2006 Apr;23(4):410-8.


Silent myocardial ischemia in patients with diabetes: who to screen.

Janand-Delenne B, Savin B, Habib G, Bory M, Vague P, Lassmann-Vague V.

Diabetes Care. 1999 Sep;22(9):1396-400.


Ischemia change in stable coronary artery disease is an independent predictor of death and myocardial infarction.

Farzaneh-Far A, Phillips HR, Shaw LK, Starr AZ, Fiuzat M, O'Connor CM, Sastry A, Shaw LJ, Borges-Neto S.

JACC Cardiovasc Imaging. 2012 Jul;5(7):715-24. doi: 10.1016/j.jcmg.2012.01.019.


Silent myocardial ischemia screening in patients with diabetes mellitus.

Barthelemy O, Le Feuvre C, Timsit J.

Arq Bras Endocrinol Metabol. 2007 Mar;51(2):285-93. Review.


Microalbuminuria predicts silent myocardial ischaemia in type 2 diabetes patients.

Giovacchini G, Cappagli M, Carro S, Borrini S, Montepagani A, Leoncini R, Mazzotta G, Sambuceti G, Mariani G, Volterrani D, Zellweger MJ, Ciarmiello A.

Eur J Nucl Med Mol Imaging. 2013 Apr;40(4):548-57. doi: 10.1007/s00259-012-2323-5. Epub 2013 Jan 12.


Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study.

Wackers FJ, Young LH, Inzucchi SE, Chyun DA, Davey JA, Barrett EJ, Taillefer R, Wittlin SD, Heller GV, Filipchuk N, Engel S, Ratner RE, Iskandrian AE; Detection of Ischemia in Asymptomatic Diabetics Investigators.

Diabetes Care. 2004 Aug;27(8):1954-61. Erratum in: Diabetes Care. 2005 Feb;28(2):504.


Progression to overt or silent CAD in asymptomatic patients with diabetes mellitus at high coronary risk: main findings of the prospective multicenter BARDOT trial with a pilot randomized treatment substudy.

Zellweger MJ, Maraun M, Osterhues HH, Keller U, Müller-Brand J, Jeger R, Pfister O, Burkard T, Eckstein F, von Felten S, Osswald S, Pfisterer M.

JACC Cardiovasc Imaging. 2014 Oct;7(10):1001-10. doi: 10.1016/j.jcmg.2014.07.010. Epub 2014 Sep 17.


Effects of percutaneous coronary interventions in silent ischemia after myocardial infarction: the SWISSI II randomized controlled trial.

Erne P, Schoenenberger AW, Burckhardt D, Zuber M, Kiowski W, Buser PT, Dubach P, Resink TJ, Pfisterer M.

JAMA. 2007 May 9;297(18):1985-91.


Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial.

Young LH, Wackers FJ, Chyun DA, Davey JA, Barrett EJ, Taillefer R, Heller GV, Iskandrian AE, Wittlin SD, Filipchuk N, Ratner RE, Inzucchi SE; DIAD Investigators.

JAMA. 2009 Apr 15;301(15):1547-55. doi: 10.1001/jama.2009.476.


Prediction of new-onset refractory congestive heart failure using gated myocardial perfusion SPECT imaging in patients with known or suspected coronary artery disease subanalysis of the J-ACCESS database.

Nakata T, Hashimoto A, Wakabayashi T, Kusuoka H, Nishimura T.

JACC Cardiovasc Imaging. 2009 Dec;2(12):1393-400. doi: 10.1016/j.jcmg.2009.09.010.


Cost-effectiveness of functional cardiac testing in the diagnosis and management of coronary artery disease: a randomised controlled trial. The CECaT trial.

Sharples L, Hughes V, Crean A, Dyer M, Buxton M, Goldsmith K, Stone D.

Health Technol Assess. 2007 Dec;11(49):iii-iv, ix-115.


Incremental prognostic value of adenosine stress myocardial perfusion single-photon emission computed tomography and impact on subsequent management in patients with or suspected of having myocardial ischemia.

Hachamovitch R, Berman DS, Kiat H, Cohen I, Lewin H, Amanullah A, Kang X, Friedman J, Diamond GA.

Am J Cardiol. 1997 Aug 15;80(4):426-33.


Silent myocardial ischemia detected by single photon emission computed tomography (SPECT) and risk of cardiac events among asymptomatic patients with type 2 diabetes: a meta-analysis of prospective studies.

Zhang L, Li H, Zhang S, Jaacks LM, Li Y, Ji L.

J Diabetes Complications. 2014 May-Jun;28(3):413-8. doi: 10.1016/j.jdiacomp.2013.11.013. Epub 2013 Dec 10.


Exercise stress tests for detecting myocardial ischemia in asymptomatic patients with diabetes mellitus.

Hage FG, Lusa L, Dondi M, Giubbini R, Iskandrian AE; IAEA Diabetes Investigators.

Am J Cardiol. 2013 Jul 1;112(1):14-20. doi: 10.1016/j.amjcard.2013.02.047. Epub 2013 Apr 8.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk